Michael Pollock has been appointed vice president of real world outcomes at Pharmaceutical Product Development, LLC (PPD). Mr. Pollock is responsible for directing and enhancing the company’s capabilities in health outcomes and evidence-based medicine to help biopharmaceutical clients optimize market and patient access to novel therapies.   Most recently, Mr. Pollock was president of Reynolds Pollock & Associates, a health outcomes research and market access strategy consulting company. He a...